Thus, we believe that our work is fundamentally different from a direct gene therapy approach of Caccamo et al. [30] who have shown that increasing brain p62 expression might be a valid approach to restore neuronal function in proteinopathies. The gene discussed is SQSTM1; the disease is proteostasis deficiencies.